FSSAI Takes Legal Action Against Nestlé India Over Infant Formula Claims
Published · Updated
AI-generated summary of the coverage listed below: The Food Safety and Standards Authority of India (FSSAI) has begun legal proceedings against Nestlé India after finding the company’s infant nutrition products made promotional claims about 5-hydroxy-methyl-2-oxovalerate (5HMOs) and whey protein that were not supported by evidence. FSSAI also flagged the products for containing biotin levels outside the prescribed range. The action follows the authority’s request for clarification on the claims, underscoring its role in ensuring infant food safety and compliance with regulatory standards.
Covered by 3 outlets across the spectrum: 0% left, 33% center, 67% right.
Who is covering this story
- Center (1): Bollywood Hungama
- Right-leaning (2): Deccan Chronicle, Times Now
Sources
- Isopure responds after Bipasha Basu alleges worms in protein powder: “Quality team evaluating pack” — Bollywood Hungama (center)
- FSSAI Initiates Legal Action Against Nestle India Over Infant Nutrition Products — Deccan Chronicle (right-leaning)
- FSSAI Flags Nestlé Infant Products: What Parents Should Know About Biotin In Baby Formula — Times Now (right-leaning)